180 related articles for article (PubMed ID: 24226327)
1. Long-acting injectable olanzapine can give rise to a condition consistent with central anticholinergic syndrome.
Skomedal T; Hanem S; Dybvik T; Ilner SO
Tidsskr Nor Laegeforen; 2013 Nov; 133(21):2238-9. PubMed ID: 24226327
[No Abstract] [Full Text] [Related]
2. Successful management of olanzapine-induced anticholinergic agitation and delirium with a continuous intravenous infusion of physostigmine in a pediatric patient.
Hail SL; Obafemi A; Kleinschmidt KC
Clin Toxicol (Phila); 2013 Mar; 51(3):162-6. PubMed ID: 23473460
[TBL] [Abstract][Full Text] [Related]
3. Challenges in the management of delirium: a case of augmentation with donepezil following inadequate response and adverse effects with risperidone.
Stocker L; Jellestad L; Jenewein J; Boettger S
Psychiatr Danub; 2015 Mar; 27(1):64-6. PubMed ID: 25751433
[No Abstract] [Full Text] [Related]
4. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning.
Burns MJ; Linden CH; Graudins A; Brown RM; Fletcher KE
Ann Emerg Med; 2000 Apr; 35(4):374-81. PubMed ID: 10736125
[TBL] [Abstract][Full Text] [Related]
5. Postinjection Delirium Syndrome Associated With Olanzapine Long-Acting Injectable.
Bengtsson C; Nilsson BM; Bodén R
J Clin Psychopharmacol; 2016 Aug; 36(4):388-9. PubMed ID: 27159773
[No Abstract] [Full Text] [Related]
6. Long-acting injectable antipsychotics and the development of postinjection delirium/sedation syndrome (PDSS).
Novakovic V; Adel T; Peselow E; Lindenmayer JP
Clin Neuropharmacol; 2013; 36(2):59-62. PubMed ID: 23503549
[TBL] [Abstract][Full Text] [Related]
7. [Post-injection delirium/sedation syndrome following injection of olanzapine pamoate: a new syndrome in emergency psychiatry].
Buts K; Van Hecke J
Tijdschr Psychiatr; 2014; 56(4):273-6. PubMed ID: 24807388
[TBL] [Abstract][Full Text] [Related]
8. Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases.
Detke HC; McDonnell DP; Brunner E; Zhao F; Sorsaburu S; Stefaniak VJ; Corya SA
BMC Psychiatry; 2010 Jun; 10():43. PubMed ID: 20537128
[TBL] [Abstract][Full Text] [Related]
9. Delirium with anticholinergic symptoms after a combination of paliperidone and olanzapine pamoate in a patient known to smoke cannabis: an unfortunate coincidence.
Kokalj A; Rijavec N; Tavčar R
BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27335358
[TBL] [Abstract][Full Text] [Related]
10. Post-Injection Delirium/Sedation Syndrome after Olanzapine Long-Acting Intramuscular Injection - Who is at Risk?
Łukasik-Głębocka M; Sommerfeld K; Teżyk A; Panieński P; Żaba C; Zielińska-Psuja B
Basic Clin Pharmacol Toxicol; 2015 Sep; 117(3):213-4. PubMed ID: 25703610
[TBL] [Abstract][Full Text] [Related]
11. [Not Available].
Mohammad M; Alaoui-Ismaili Z; Baandrup L; Barzanji AF
Ugeskr Laeger; 2023 May; 185(19):. PubMed ID: 37170738
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine long-acting injection: a review of first experiences of post-injection delirium/sedation syndrome in routine clinical practice.
Bushe CJ; Falk D; Anand E; Casillas M; Perrin E; Chhabra-Khanna R; Detke HC
BMC Psychiatry; 2015 Apr; 15():65. PubMed ID: 25886006
[TBL] [Abstract][Full Text] [Related]
13. [Olanzapine pamoate injection -- experience and case reports from Hungarian clinical practice].
Sümegi A; Kálmán J; Csekey L
Neuropsychopharmacol Hung; 2013 Jun; 15(2):105-17. PubMed ID: 23817361
[TBL] [Abstract][Full Text] [Related]
14. Postinjection Delirium/Sedation Syndrome After 31st Long-Acting Olanzapine Depot Injection.
Venkatesan V; Khanra S; Mandal K; Deepak MB
Clin Neuropharmacol; 2019; 42(2):64-65. PubMed ID: 30747749
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine postinjection delirium/sedation syndrome: an unrecognized diagnosis in the emergency department.
Vodovar D; Malissin I; Deye N; Baud FJ; Mégarbane B
J Emerg Med; 2014 Jul; 47(1):e23-4. PubMed ID: 24199723
[No Abstract] [Full Text] [Related]
16. Physostigmine versus diazepines for anticholinergic poisoning.
Oakley P
Ann Emerg Med; 2001 Feb; 37(2):239-41. PubMed ID: 11174251
[No Abstract] [Full Text] [Related]
17. Olanzapine pamoate for the treatment of schizophrenia.
Naber D
Expert Opin Pharmacother; 2011 Mar; 12(4):627-33. PubMed ID: 21254860
[TBL] [Abstract][Full Text] [Related]
18. [Olanzapine long-acting post-injection syndrome: a case report and brief review].
Duran-Sindreu SF; Grasa-Bello E; Corripio-Collado I; Sauras-Quetcuti RB; Keymer-Gausset A; Roldán-Bejarano A; Alonso-Solís A; Figueras-Vilalta M; Álvarez-Martínez E
Actas Esp Psiquiatr; 2013; 41(1):60-2. PubMed ID: 23440537
[TBL] [Abstract][Full Text] [Related]
19. [Drug therapy of delirium in the elderly].
Ranhoff AH
Tidsskr Nor Laegeforen; 2004 Dec; 124(23):3072-4. PubMed ID: 15586192
[No Abstract] [Full Text] [Related]
20. Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia.
Kane JM; Detke HC; Naber D; Sethuraman G; Lin DY; Bergstrom RF; McDonnell D
Am J Psychiatry; 2010 Feb; 167(2):181-9. PubMed ID: 20008947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
